drugset / Trial / NCT06265051

Tirofiban After Successful MT Recanalization in AIS

NCT06265051

Phase 2/3 Completed 1380 enrolled Xiang Luo Affiliated Hospital of Shandong University of Traditional Chinese Medicine · collabCR & WISCO General Hospital · collabCentral Hospital of Xiaogan · collabChengdu Fifth People's Hospital · collabDali Bai Autonomous Prefecture People's Hospital · collabEzhou Central Hospital · collabFirst Affiliated Hospital of Fujian Medical University · collabFirst People's Hospital of Xianyang · collabFujian Medical University Union Hospital · collabFujian Provincial Hospital · collabGaoyou People's Hospital · collabGeneral Hospital of the Yangtze River Shipping · collabHanyang Hospital Affiliated to Wuhan University of Science and Technology · collabHuangshi Central Hospital · collabHubei Provincial Hospital of Integrated Chinese & Western Medicine · collabHubei University of Medicine · collabJiangxi Provincial People's Hopital · collabJingmen Central Hospital · collabJingmen People's Hospital · collabJingzhou Hospital Affiliated to Yangtze University · collabJiujiang No.1 People's Hospital · collabLiuZhou People's Hospital · collabLongyan First Affiliated Hospital of Fujian Medical University · collabLoudi Central Hospital · collabLu'an People's Hospital of Anhui Hospital · collabMinda Hospital of Hubei Minzu University · collabNanyang Central Hospital · collabPuren Hospital Affiliated to Wuhan University of Science and Technology · collabQingdao Central Hospital · collabQuanzhou First Hospital · collabQujing Central Hospital of Yunnan Province · collabRenmin Hospital of Wuhan University · collabSecond Affiliated Hospital of Soochow University · collabSecond Xiangya Hospital of Central South University · collabShanghai East Hospital · collabShanxi Provincial People's Hospital · collabShenzhen Hospital of Southern Medical University · collabShiyan Renmin Hospital · collabTaihe Hospital, Affiliated Hospital of Hubei Province of Medicine · collabTaizhou First People's Hospital · collabThe Affiliated Hospital Of Southwest Medical University · collabThe Central Hospital of Enshi Tujia And Miao Autonomous Prefecture · collabThe Central Hospital of Huanggang · collabThe Cerebrovascular Hospital of Hubei Province · collabThe Fifth Hospital of Wuhan · collabThe First Affiliated Hospital of BaoTou Medical College · collabThe First Affiliated Hospital of Nanchang University · collabThe First People's Hospital of Changde City · collabThe First People's Hospital of Jiangxia District · collabThe First People's Hospital of Jingzhou City · collabThe First People's Hospital of TianMen in Hubei Province · collabThe Fourth Hospital of Wuhan · collabThe Lichuan ethnic Hospital of Traditional Chinese Medicine · collabThe Second People's Hospital of Jingzhou City · collabThe Third People's Hospital of Hubei Province · collabThe Third People's Hospital of Jingzhou City · collabThree Gorges Hospital of Chongqing University · collabTongcheng People's Hospital · collabWuhan Central Hospital · collabWuhan Hankou Hospital · collabWuhan No.1 Hospital · collabWuhan Third Hospital · collabXianfeng People's Hospital · collabXiangyang Central Hospital People's Hospital of Huangpi District · collabXiangyang Hospital of Traditional Chinese Medicine · collabXiangyang No 1 People's Hospital Affiliated to Hubei University of Medicine · collabXiangzhou People's Hospital · collabXianning Central Hospital · collabXiaogan First People's Hospital · collabXihua People's Hospital · collabXingyi People's Hospital · collabYichang Central People's Hospital of China Three Gorges University · collabYingtan People's Hospital · collabZaoyang First People's Hospital · collabZhongnan Hospital · collabZhongxiang Hospital of Traditional Chinese Medicine · collabZhongxiang People's Hospital · collabZigong No.1 Peoples Hospital · collabZoucheng City People's Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Acute ischemic stroke with large vessel occlusion is a frequently occurring life-threatening condition. Although endovascular treatment can effectively open occluded vessels, the successful reperfusion rate exceeds 80%, but the rate of good prognosis is less than 50%. The current clinical focus is on how to improve futile recanalization. Tirofiban is widely used in the treatment of stroke, as it can effectively prevent vascular reocclusion and improve microcirculation perfusion. It has the potential to improve futile recanalization, but there is a lack of high-level evidence-based medical support. This multicenter, prospective, double-blind, randomized controlled trial was conducted to assess the effectiveness and safety of sequential tirofiban therapy following successful mechanical thrombectomy within 24 hours of onset.

Timeline

Start
2024-04-09
Primary completion
2025-12-29
Completion
2025-12-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirofiban Other / unclassified 0.1 ug/kg Intravenous